This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vyas, N.
Right arrow Articles by Wyandt, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vyas, N.
Right arrow Articles by Wyandt, C. M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2002, p. 105-109, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.1.105-109.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Carrier-Mediated Partitioning of Artemisinin into Plasmodium falciparum-Infected Erythrocytes

Nehal Vyas,1 Bonnie A. Avery,1,2* Mitchell A. Avery,2,3 and Christy M. Wyandt1,2

Department of Pharmaceutics,1 National Center for Natural Products Research and Research Institute of Pharmaceutical Sciences,2 Departments of Chemistry and Medicinal Chemistry, University of Mississippi, University, Mississippi 386773

Received 23 October 2000/ Returned for modification 18 June 2001/ Accepted 11 September 2001

The purpose of the present study was to characterize the partitioning of artemisinin into both uninfected and Plasmodium falciparum-infected red blood cells (RBCs). The partitioning of [14C](+)-artemisinin into RBCs was studied at four different hematocrit levels and eight time periods. At the optimum time of 2 h, the partitioning process was investigated with eight different drug concentrations ranging from 0.88 to 3.52 µM at 37 and 4°C. The effect of the presence of unlabeled artemisinin on the partitioning of the same concentration of [14C]artemisinin was studied. About 35 to 40% of the drug was seen to partition into uninfected RBCs at a hematocrit of 33%, irrespective of the incubation period or the drug concentration used. In contrast, infected RBCs showed an increase in partitioning of the drug with time until saturation was achieved at 1 h. While the partitioning of artemisinin into parasitized RBCs at 37°C was found to be significantly higher than that in nonparasitized RBCs, at 4°C both parasitized and nonparasitized RBCs showed identical partitioning of the drug. The partitioning of [14C]artemisinin into parasitized RBCs was completely inhibited in the presence of the same concentration of unlabeled artemisinin. However, no such effect was observed in nonparasitized cells, and no evidence suggesting that binding of the drug in parasitized RBCs is reversible was found. The partitioning of artemisinin into parasitized RBCs was found to be rapid, saturable, temperature dependent, irreversible, and subject to competitive inhibition with unlabeled artemisinin. The results obtained suggest the involvement of carrier mediation in the partitioning of artemisinin across the parasitized RBC membrane. In contrast, simple passive diffusion of artemisinin was seen in nonparasitized RBCs.


* Corresponding author. Mailing address: School of Pharmacy, Department of Pharmaceutics, Room 107, Faser Hall, University of Mississippi, University, MS 38677. Phone: (662) 915-5163. Fax: (662) 915-1177. E-mail: bavery{at}olemiss.edu.


Antimicrobial Agents and Chemotherapy, January 2002, p. 105-109, Vol. 46, No. 1
0066-4804/01/$04.00+0     DOI: 10.1128/AAC.46.1.105-109.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • OSORIO, L., MURILLO, C., APONTE, S., MAYAGAYA, V., SCHEURER, C., BRUN, R., MATILE, H., WITTLIN, S. (2007). IN VITRO SUSCEPTIBILITY OF P. FALCIPARUM POPULATIONS FROM COLOMBIA AND TANZANIA TO A NEW SYNTHETIC PEROXIDE (OZ277). Am J Trop Med Hyg 76: 1024-1026 [Abstract] [Full Text]  
  • Maerki, S., Brun, R., Charman, S. A., Dorn, A., Matile, H., Wittlin, S. (2006). In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum. J Antimicrob Chemother 58: 52-58 [Abstract] [Full Text]